These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 1899364)

  • 1. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial.
    Gore JM; Sloan M; Price TR; Randall AM; Bovill E; Collen D; Forman S; Knatterud GL; Sopko G; Terrin ML
    Circulation; 1991 Feb; 83(2):448-59. PubMed ID: 1899364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience.
    Sloan MA; Price TR; Terrin ML; Forman S; Gore JM; Chaitman BR; Hodges M; Mueller H; Rogers WJ; Knatterud GL; Braunwald E
    Stroke; 1997 Jun; 28(6):1107-14. PubMed ID: 9183334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
    Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK
    Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
    Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
    Gore JM; Granger CB; Simoons ML; Sloan MA; Weaver WD; White HD; Barbash GI; Van de Werf F; Aylward PE; Topol EJ
    Circulation; 1995 Nov; 92(10):2811-8. PubMed ID: 7586246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
    Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
    N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial thrombolysis using rt-PA in patients with acute stroke due to vessel occlusion of anterior and/or posterior cerebral circulation.
    Tountopoulou A; Ahl B; Weissenborn K; Becker H; Goetz F
    Neuroradiology; 2008 Jan; 50(1):75-83. PubMed ID: 17917723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral hematoma related to thrombolysis for myocardial infarction.
    Kaufman HH; McAllister P; Taylor H; Schmidt S
    Neurosurgery; 1993 Nov; 33(5):898-900; discussion 900-1. PubMed ID: 8264890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic risk factors after rt PA thrombolysis in acute cerebral infarction.
    Liu L; Luo GQ; Liu Q; Yang ZY
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5542-5551. PubMed ID: 37401290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
    Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
    Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
    Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
    J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Headache, thrombolytic therapy, and chronic subdural hemorrhage--a case report.
    Nathan PE; Sonenblick D; Chakote V; Wolf R; Sacchi TJ
    Angiology; 1994 Jan; 45(1):77-80. PubMed ID: 8285390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis.
    Kase CS; O'Neal AM; Fisher M; Girgis GN; Ordia JI
    Ann Intern Med; 1990 Jan; 112(1):17-21. PubMed ID: 2104561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
    Nisar T; Hanumanthu R; Khandelwal P
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
    Da Silva VF; Bormanis J
    Neurosurgery; 1992 Jun; 30(6):943-5. PubMed ID: 1614602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorrhagic complications of thrombolytic therapy.
    Vujković Z; Racić D; Miljković S; Dajić V
    Med Pregl; 2012; 65(1-2):9-12. PubMed ID: 22452232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.